Physiomer (Spray) Instructions for Use
ATC Code
R01AX10 (Other drugs)
Active Substance
Sea water (Grouping name)
Clinical-Pharmacological Group
Drug for moisturizing, cleansing, and protecting the nasal mucosa
Pharmacotherapeutic Group
Remedy for nasal conditions
Pharmacological Action
A product for intranasal use. It helps to maintain the normal physiological state of the nasal mucosa.
It helps to thin mucus and facilitates its removal from the nose. The trace elements contained in sea water improve the function of the ciliated epithelium, which increases the resistance of the nasal mucosa to pathogenic bacteria and viruses. In allergic rhinitis, it helps to remove allergens from the nasal mucosa.
Indications
- Acute and chronic inflammatory diseases of the nose, paranasal sinuses, and nasopharynx.
- Prevention of infectious diseases of the nose and nasopharynx.
- Allergic and vasomotor rhinitis.
- Prevention of inflammatory processes after surgical interventions.
- Daily hygiene of the nasal cavity to preserve the protective properties of the mucosa under conditions of increased dryness or air pollution.
ICD codes
| ICD-10 code | Indication |
| J00 | Acute nasopharyngitis (common cold) |
| J01 | Acute sinusitis |
| J06.9 | Acute upper respiratory infection, unspecified |
| J30.0 | Vasomotor rhinitis |
| J30.1 | Allergic rhinitis due to pollen |
| J30.3 | Other allergic rhinitis (perennial allergic rhinitis) |
| J31.0 | Chronic rhinitis (including ozaena, atrophic and hypertrophic rhinitis) |
| J31.1 | Chronic nasopharyngitis |
| J32 | Chronic sinusitis |
| Z54.0 | Convalescence following surgery |
| ICD-11 code | Indication |
| CA00 | Acute nasopharyngitis |
| CA01 | Acute rhinosinusitis |
| CA07.0 | Acute upper respiratory tract infection of unspecified site |
| CA08.00 | Allergic rhinitis due to pollen |
| CA08.03 | Other allergic rhinitis |
| CA08.3 | Vasomotor rhinitis |
| CA09.0 | Chronic rhinitis |
| CA09.1 | Chronic nasopharyngitis |
| CA0A.Z | Chronic rhinosinusitis, unspecified |
| QB7Y | Other specified convalescence |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer intranasally. For therapeutic purposes, use 4-6 times per day.
For daily hygienic purposes, use 1-4 times per day.
In children starting from 2 weeks of age and in adults, use the appropriate dosage form.
Spray
Applied intranasally in children, starting from 2 weeks of age (in the appropriate dosage form), and in adults for therapeutic purposes 4-6 times/day, for hygienic purposes – 1-4 times/day.
Adverse Reactions
Allergic reactions are possible.
Discontinue use and consult a physician if any adverse reactions occur.
Contraindications
- Do not use in children under 2 weeks of age due to lack of data.
- Hypersensitivity to any component of the preparation.
Use in Pregnancy and Lactation
Can be used during pregnancy and breastfeeding if indicated.
Pediatric Use
Data on use in children under 2 weeks of age are not available.
In children over 2 weeks of age, it is used in the appropriate dosage form.
Geriatric Use
The drug is approved for use in elderly patients.
Special Precautions
Consultation with a doctor is required if use after surgery is necessary.
Drug Interactions
Can be used with other medicines as part of combination therapy.
No clinically significant drug interactions have been reported.
Maintain a short interval between the use of this product and other intranasal medications.
Overdose
Overdose is unlikely due to the nature of the preparation.
In case of accidental ingestion of a large volume, seek medical attention if symptoms are severe or persistent.
Storage Conditions
Store at 2°C (36°F) to 30°C (86°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Nasal spray: 135 ml canister with a spray nozzle
Marketing Authorization Holder
Laboratoire de la Mer (France)
Dosage Form
| Physiomer | Nasal spray: 135 ml canister with a spray nozzle |
Dosage Form, Packaging, and Composition
| Nasal spray | 1 canister |
| Sea water | 135 ml |
135 ml – polyethylene canisters (1) complete with a spray nozzle – cardboard packs.
Nasal spray for children: 115 ml canister with a spray nozzle
Marketing Authorization Holder
Laboratoire de la Mer (France)
Dosage Form
| Physiomer | Nasal spray for children: 115 ml canister with a spray nozzle |
Dosage Form, Packaging, and Composition
| Nasal spray for children | 1 canister |
| Sea water | 115 ml |
115 ml – polyethylene canisters (1) complete with a spray nozzle – cardboard packs.
Nasal spray: 210 ml canister with a spray nozzle
Marketing Authorization Holder
Laboratoire de la Mer (France)
Dosage Form
| Physiomer | Nasal spray: 210 ml canister with a spray nozzle |
Dosage Form, Packaging, and Composition
| Nasal spray | 1 canister |
| Sea water | 210 ml |
210 ml – polyethylene canisters (1) complete with a spray nozzle – cardboard packs.
OKI, sachets 80mg 2g, 12pcs
Fenotropil pills 100mg, 60pcs
Mildronate capsules 500mg, 90pcs
Kagocel pills 12mg, 30pcs
Phenibut-Vertex pills 250mg, 20pcs
Picamilon pills 50mg, 60pcs
Belosalic, lotion solution for external use spray 100ml
Ingavirin capsules 90mg, 10pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Daivobet, ointment, 30g
No-spa pills 40mg, 64pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Noopept, pills 10mg, 50pcs
Belosalic, ointment, 30g 